SBBP
Strongbridge Biopharma plc.
SBBP
SBBP
Delisted
SBBP was delisted on the 5th of October, 2021.
60 hedge funds and large institutions have $48.8M invested in Strongbridge Biopharma plc. in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 20 increasing their positions, 18 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
2% less capital invested
Capital invested by funds: $49.7M → $48.8M (-$898K)
Holders
60
Holding in Top 10
1
Calls
$6K
Puts
–
Top Buyers
| 1 | +$6.41M | |
| 2 | +$734K | |
| 3 | +$673K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$671K |
| 5 |
Renaissance Technologies
New York
|
+$610K |
Top Sellers
| 1 | -$2.63M | |
| 2 | -$1.36M | |
| 3 | -$1.26M | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$903K |
| 5 |
D.E. Shaw & Co
New York
|
-$639K |